 Crinetics Pharmaceuticals Inc NASDAQ:CRNX Analysts at Piper Sandler issued their FY2024 earnings per share EPS estimates for Crinetics Pharmaceuticals in a research report issued on Monday, March 9th. Piper Sandler analyst T. Van. Buren forecasts that the company will earn 4.80 per share for the year. Crinetics Pharmaceuticals NASDAQ:CRNX last posted its quarterly earnings ... 